Ganciclovir-resistant, cytomegalic interstitial lung disease in a patient with systemic lupus erythematosus.
A patient with systemic lupus erythematosus developed interstitial lung disease initially felt to be a manifestation of the disease but that, on further workup, proved to be a manifestation of cytomegalic disease resistant to ganciclovir. Treatment with foscarnet was associated with prompt improvement.
Finger
Eduardo
E
Department of Medicine, Hospital Israelita Albert Einstein and Research Institute, Avenida Albert Einstein, 27-Cj 1209m, Morumbi, Sao Paulo-SP, CEP 05652-000, Brazil. eduardofinger@hotmail.com
Romaldini
Helio
H
Lewi
David Salomão
DS
Scheinberg
Morton Aaron
MA
D000998:Antiviral Agents / Q000494:pharmacology; D003587:Cytomegalovirus / Q000378:metabolism*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000175:diagnosis; D005260:Female; D015774:Ganciclovir / Q000494:pharmacology*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000821:virology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D008177:Lupus Vulgaris / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D008875:Middle Aged; D011014:Pneumonia / Q000150:complications / Q000175:diagnosis / Q000821:virology*; D016896:Treatment Outcome
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir